The 2027 Executives to Watch: The Doctors Company’s Todd Zeiter
In April of 2026, The Doctors Company appointed Todd Zeiter as its chief underwriting officer. Then in June, it announced the closure of its acquisition of medical malpractice insurer Proassurance.
The combined entity reports that it now offers coverage to more than 175,000 members and insureds.
To help manage a high volume of submissions, the company recently rolled out a Technology Assisted Underwriting Tool, which was developed by its actuarial teams, the company’s Innovation lab and its IT department.
“TAU helps us respond to agents and brokers more quickly while maintaining the thoughtful risk assessment our members and insureds expect,” Zeiter said.
“We have re-engineered our submission process, reducing it from a few dozen steps to a handful, so that submissions move through intake and triage more efficiently,” he added.
While medical malpractice claims have declined in frequency in recent years, the severity isn’t going away any time soon.
“Medical malpractice claims are becoming more expensive, volatile, and consequential, even as overall claim frequency has declined from historical levels,” Zeiter stated.
“Severity is rising through larger settlements, higher indemnity payments, and nuclear verdicts. Because MPL is a long-tail line, those severity trends can take years to fully emerge and can create rate pressure even when claim counts remain relatively low. The most significant challenge will be balancing affordability and access to capacity with continued pressure from claim severity, rising defense costs, and greater reinsurance scrutiny. Those trends will not affect every insured in the same way. Specialty, venue, loss experience, limits, and the strength of an organization’s risk controls will increasingly determine pricing and available capacity, particularly in higher excess layers and more challenging jurisdictions,” he added.
In addition to the TAU, Zeiter said the acquisition of Proassurance will give The Doctors Company the heft to address its insureds needs in the pressurized environment of health care.
“The combination of companies gives us a broader platform, deeper expertise, and greater institutional knowledge to help clinicians and organizations meet the challenges they face,” he said.
“Pairing disciplined underwriting that uses technology to improve the precision and speed of decision-making with our physician ownership, industry-leading claims database, and decades of MPL experience helps us look beyond broad market signals to evaluate the factors shaping each insured’s exposure. This insight allows us to recognize well-managed risks, deploy capacity responsibly, and provide greater stability through changing market conditions. We also will continue investing in claims expertise, patient safety and risk management resources, and clear communication with members and agents.” &
To view all the 2027 Executives to Watch, visit here.


